# US 2024/0197958 A1 · Hybrid, artificial bone tissue implant absorbing mechanical vibrations, whose architectural structure imitates trabecular bone, allowing the saturation of bone marrow, blood, and nutrients, supporting autological regeneration, which can be used with titanium structures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197958 A1
- Document ID: US20240197958A1
- Status: Published application
- Kind: A1
- Application number: 18/286,764
- Filed: 2021-12-26
- Published: 2024-06-20
- Earliest claimed: 2021-04-17
- Assignees: Bloocell Saglik Teknolojileri Sanayi Ve Ticaret Limited Sirketi
- Applicants: Bloocell Saglik Teknolojileri Sanayi Ve Ticaret Limited Sirketi
- Inventors: Gazi HURI; Oktay TOPALOGLU; Mustafa Cüneyt CIKMAN
- Web page: https://patentgrep.com/patent/US20240197958A1

## CPC

- A61F 2/28: Bones
- A61L 27/34: Macromolecular materials
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- B33Y 80/00: Products made by additive manufacturing
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/30062: {(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive}
- A61F 2310/00293: containing a phosphorus-containing compound, e.g. apatite
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61L 2430/24: for joint reconstruction
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

A polymer scaffold structure is created as a result of the proportional combination of β-Tricalcium Phosphate (β-TCP) that will increase the 3D and osteoconductive effect allowing/supporting cell infiltration by using extrusion deposition, in other words, added manufacturing process, and with physiological buffered HA solution with the Deep Coating Method and by increasing the transmission rate of growth factors as a result of coating and expanding their areas with the biological tissue implant, which allows its use with titanium mesh plates or contoured structures.

## Claims

### Claim 1

A method of obtaining a three-dimensional polymer and β-tricalcium phosphate (β-TCP) scaffold structure (tissue scaffold) that allows/supports cell infiltration using an additive manufacturing process, coating with physiological buffered HA solution with deep coting method, and obtaining a biological tissue implant that allows an use of titanium mesh plate or contoured structures to increase a transmission rate of growth factors and expand the areas, wherein
filament layers, which are connected to each other at angles that will support extracellular matrix (ECM) interaction and overlapped by connecting at 90 degrees with each other,
overlapping the third filament layer as oblig,
supporting vascularized tissue formation of the obtained structures together with osteoconductive effect in 50-70 micron pore structure,
increasing a deep encapsulation of hyaluronic acid into the body by creating micro cracks on the body with the cryo-shock method or vacuum drying system of the three-dimensional tissue scaffold formed as a result of extrusion, and
attachment and coating of the empass or hot polymer to a surface of the titanium mesh by extrusion.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the correct combination of the no-booster and hydrogel polymer the hyaluronic acid coating method performed to produce mechanically sound, electrically conductive, bioactive;
with the correct combination of nano-enhancer and hydrogel polymer, mechanically sound, electrically conductive, hyaluronic acid coating method performed to produce bioactive;
preparation of solutions with magnetic stirrer at room temperature with 10 mg/ml sodium hyaluronate (1 million Da, medical grade) in physiological buffer (PBS pH 7.4),
covering the tissue scaffolds with the bottom-coating (immersion) method in the solution, and
it is that it is left to dry for 3 days at 50° C. in a vacuum incubator.

### Claim 3 (depends on 1)

The method according to claim 1, wherein cross-links in HA molecules are used to ensure that the hyaluronic acid molecule is permanent in the implant.

### Claim 4 (depends on 1)

The method according to claim 1, wherein microcracks is formed on the body with the cryo-shock method in the 3D tissue scaffold forming as a result of the extrusion.

### Claim 5 (depends on 1)

The method according to claim 1, wherein in the biological tissue implant, a cartilage repair patch is adapted to be placed on a first outer cell occlusive layer near a subchondral bone wound site.

### Claim 6 (depends on 1)

The method according to claim 1, wherein in the biological tissue implant, a second outer cell is presented and has a permeable HA layer and a cartilagenic matrix (architecture) placed between the first and second layers.

### Claim 7 (depends on 1)

The method according to claim 1, wherein in the biological tissue implant, a cartilagenic matrix and the formed permeate layer surface area are provided with the property of a receiving point for the diffusion of autologous stem cells, and components supporting the production of hyaline-like cartilage are contained in the presence of autologous stem cells.

### Claim 8 (depends on 1)

The method according to claim 1, wherein in the biological tissue implant, as fully supporting bone augmentation, acting as a barrier with high-density polymer tissue, helping the regeneration, providing potential fibrovascular growth, covering the polymer structure on titanium mesh, giving form and volume to the tissue which has lost its volumetric integrity, growing the tissue inward and a hybrid structure.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the biological tissue implant has a cylindrical, square, free-form shape specially for the person.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the biological tissue implant, the therapeutic concentration, stem cell, growth factor is integrated into the scaffold structure, if desired.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the biological tissue implant, β-tricalcium phosphate (β-TCP), a biocompatible, radiopaque and resorbable osteoconductive material is included in the prepared PCL granule at a rate of 3-15%, supporting new bone formation in the defect area.

### Claim 12 (depends on 2)

The method according to claim 2, wherein cross-links in HA molecules are used to ensure that the hyaluronic acid molecule is permanent in the implant.

### Claim 13 (depends on 2)

The method according to claim 2, wherein microcracks is formed on the body with the cryo-shock method in the 3D tissue scaffold forming as a result of the extrusion.

### Claim 14 (depends on 3)

The method according to claim 3, wherein microcracks is formed on the body with the cryo-shock method in the 3D tissue scaffold forming as a result of the extrusion.

### Claim 15 (depends on 2)

The method according to claim 2, wherein in the biological tissue implant, a cartilage repair patch is adapted to be placed on a first outer cell occlusive layer near a subchondral bone wound site.

### Claim 16 (depends on 3)

The method according to claim 3, wherein in the biological tissue implant, a cartilage repair patch is adapted to be placed on a first outer cell occlusive layer near a subchondral bone wound site.

### Claim 17 (depends on 4)

The method according to claim 4, wherein in the biological tissue implant, a cartilage repair patch is adapted to be placed on a first outer cell occlusive layer near a subchondral bone wound site.

### Claim 18 (depends on 2)

The method according to claim 2, wherein in the biological tissue implant, a second outer cell is presented and has a permeable HA layer and a cartilagenic matrix (architecture) placed between the first and second layers.

### Claim 19 (depends on 3)

The method according to claim 3, wherein in the biological tissue implant, a second outer cell is presented and has a permeable HA layer and a cartilagenic matrix (architecture) placed between the first and second layers.

### Claim 20 (depends on 4)

The method according to claim 4, wherein in the biological tissue implant, a second outer cell is presented and has a permeable HA layer and a cartilagenic matrix (architecture) placed between the first and second layers.
